50881-013 : Monjuvi 200 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 50881-013
Labeler: Incyte Corporation
Product Type: Human Prescription Drug
Drug Name:  Monjuvi
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA761163
Rev. Date: 


NDC Package Codes:

  • 50881-013-01: 1 VIAL IN 1 CARTON (50881‑013‑01) / 5 ML IN 1 VIAL
  • 50881-013-03: 1 VIAL IN 1 CARTON (50881‑013‑03) / 5 ML IN 1 VIAL

Active Ingredients:

  • Tafasitamab

Dosage Strength:

  • 200 mg/5mL

Related Products:

Based on records with the same trade name.
  • 73535-208 Monjuvi 200 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Morphosys Us Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50881-013 QR Code

< Prev: 50881-012Next: 50881-015 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.